Pharming Group N.V. ADR (PHAR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 66,661 | 54,900 | 42,541 | 0 | 54,200 |
| Cost of Goods | 8,295 | 5,700 | 4,075 | N/A | 2,300 |
| Gross Profit | 58,366 | 49,200 | 38,466 | N/A | 51,900 |
| Operating Expenses | 56,753 | 44,600 | 52,204 | 0 | 44,400 |
| Operating Income | 1,908 | 5,300 | -13,663 | N/A | 7,800 |
| Other Income | 1,399 | -1,900 | -3,011 | 0 | 1,500 |
| Pre-tax Income | 3,307 | 3,400 | -16,674 | 0 | 9,300 |
| Income Tax | -157 | 2,100 | -4,466 | N/A | 200 |
| Net Income Continuous | 3,464 | 1,300 | -12,208 | N/A | 9,100 |
| Net Income | $3,464 | $1,300 | $-12,208 | $N/A | $9,100 |
| EPS Basic Total Ops | 0.05 | -0.02 | -0.19 | N/A | 0.14 |
| EPS Basic Continuous Ops | 0.05 | -0.02 | -0.19 | N/A | 0.14 |
| EPS Diluted Total Ops | 0.05 | -0.02 | -0.19 | N/A | 0.13 |
| EPS Diluted Continuous Ops | 0.05 | -0.02 | -0.19 | N/A | 0.13 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | N/A | -0.19 | N/A |
| EBITDA(a) | $4,810 | $8,462 | $-11,357 | $N/A | $7,800 |